TRIB NASDAQ
Trinity Biotech plc
1W: -15.8%
1M: -40.7%
3M: +1301.5%
YTD: +662.5%
1Y: +457.8%
3Y: -68.0%
5Y: -89.6%
$5.69
-0.63 (-9.97%)
Weekly Expected Move ±7.9%
$5
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$103M
+73.8% ▲
5Y CAGR: -4.7%
Total Liabilities
$138M
+66.1% ▲
5Y CAGR: +1.8%
Shareholders Equity
-$35M
-46.9% ▼
Cash & Investments
$5M
+40.0% ▲
5Y CAGR: -20.6%
Total Debt
$101M
+49.4% ▲
5Y CAGR: +4.2%
Net Debt
$96M
+50.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $27M | $26M | $7M | $4M | $5M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $27M | $26M | $7M | $4M | $5M |
| Net Receivables | $25M | $16M | $16M | $13M | $15M |
| Inventory | $30M | $29M | $23M | $20M | $19M |
| Other Current Assets | $0 | $0 | $1K | $0 | $0 |
| Total Current Assets | $83M | $73M | $47M | $39M | $41M |
| Property, Plant & Equip. | $9M | $6M | $6M | $2M | $5M |
| Goodwill & Intangibles | $34M | $36M | $35M | $16M | $51M |
| Long-Term Investments | $441K | $151K | $212K | $214K | $2M |
| Other Non-Current Assets | $64K | $56K | $55K | $43K | $194K |
| Total Non-Current Assets | $47M | $46M | $45M | $20M | $62M |
| Total Assets | $130M | $119M | $92M | $59M | $103M |
| — Liabilities — | |||||
| Accounts Payable | $7M | $7M | $6M | $4M | $7M |
| Short-Term Debt | $3M | $83M | $210K | $210K | $210K |
| Deferred Revenue | $4M | $141K | $114K | $50K | $197K |
| Other Current Liabilities | $760K | $249K | $153K | $160K | $3M |
| Total Current Liabilities | $27M | $100M | $17M | $15M | $32M |
| Long-Term Debt | $83M | $0 | $58M | $55M | $88M |
| Other Non-Current Liab. | $1M | $0 | $2M | $526K | $4M |
| Total Non-Current Liabilities | $106M | $19M | $77M | $68M | $106M |
| Total Liabilities | $133M | $119M | $94M | $83M | $138M |
| — Equity — | |||||
| Common Stock | $1M | $1M | $2M | $2M | $4M |
| Retained Earnings | $11M | $13M | -$27M | -$49M | -$79M |
| Accumulated OCI | -$5M | -$5M | -$6M | $1M | -$5M |
| Total Stockholders Equity | -$2M | -$319K | -$2M | -$24M | -$35M |
| Total Liabilities & Equity | $130M | $119M | $92M | $59M | $103M |
| — Key Metrics — | |||||
| Total Debt | $104M | $99M | $72M | $67M | $101M |
| Net Debt | $77M | $73M | $52M | $64M | $96M |
| Total Investments | $441K | $151K | $212K | $214K | $2M |